Cargando…
Calculated plasma volume status and outcomes in patients undergoing transcatheter aortic valve replacement
AIMS: This study investigated the prognostic value of plasma volume status (PVS) in patients who underwent transcatheter aortic valve replacement (TAVR). METHODS AND RESULTS: Plasma volume status was calculated in 2588 patients who underwent TAVR using data from the Japanese multicentre registry. Al...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120354/ https://www.ncbi.nlm.nih.gov/pubmed/33666353 http://dx.doi.org/10.1002/ehf2.13270 |
_version_ | 1783692062590238720 |
---|---|
author | Shimura, Tetsuro Yamamoto, Masanori Yamaguchi, Ryo Adachi, Yuya Sago, Mitsuru Tsunaki, Tatsuya Kagase, Ai Koyama, Yutaka Otsuka, Toshiaki Yashima, Fumiaki Tada, Norio Naganuma, Toru Yamawaki, Masahiro Yamanaka, Futoshi Shirai, Shinichi Mizutani, Kazuki Tabata, Minoru Ueno, Hiroshi Takagi, Kensuke Watanabe, Yusuke Hayashida, Kentaro |
author_facet | Shimura, Tetsuro Yamamoto, Masanori Yamaguchi, Ryo Adachi, Yuya Sago, Mitsuru Tsunaki, Tatsuya Kagase, Ai Koyama, Yutaka Otsuka, Toshiaki Yashima, Fumiaki Tada, Norio Naganuma, Toru Yamawaki, Masahiro Yamanaka, Futoshi Shirai, Shinichi Mizutani, Kazuki Tabata, Minoru Ueno, Hiroshi Takagi, Kensuke Watanabe, Yusuke Hayashida, Kentaro |
author_sort | Shimura, Tetsuro |
collection | PubMed |
description | AIMS: This study investigated the prognostic value of plasma volume status (PVS) in patients who underwent transcatheter aortic valve replacement (TAVR). METHODS AND RESULTS: Plasma volume status was calculated in 2588 patients who underwent TAVR using data from the Japanese multicentre registry. All‐cause mortality and heart failure hospitalization (HFH) within 2 years of TAVR were compared among the PVS quartiles (Q1, PVS < 5.5%; Q2, PVS 5.5–13.5%; Q3, PVS 13.5–21.0%; and Q4, PVS ≥ 21.0%). Subgroups were stratified by the PVS cut‐off value combined with the New York Heart Association (NYHA) class as follows: low PVS with NYHA I/II (n = 959), low PVS with NYHA III/IV (n = 845), high PVS with NYHA I/II (n = 308), and high PVS with NYHA III/IV (n = 476). The cumulative all‐cause mortality and HFH within 2 years of TAVR significantly increased with increasing PVS quartiles [8.5%, 16.8%, 19.2%, and 27.0% (P < 0.001) and 5.8%, 8.7%, 10.3%, and 12.9% (P < 0.001), respectively]. The high‐PVS group regardless of the NYHA class had a higher all‐cause mortality and HFH [9.6%, 18.2%, 24.5%, and 30.4% (P < 0.001) and 6.1%, 10.4%, 14.1%, and 11.3% (P < 0.001)]. In a Cox regression multivariate analysis, the PVS values of Q3 and Q4 had independently increased all‐cause mortality [hazard ratio (HR), 1.50 and 1.64 (P = 0.017 and P = 0.008), respectively], and Q4 had independently increased HFH (HR, 1.98, P = 0.005). The low PVS with NYHA III/IV, high PVS with NYHA I/II, and high PVS with NYHA III/IV also had significantly increased all‐cause mortality [HR, 1.45, 1.73, and 1.86 (P = 0.006, P = 0.002, and P < 0.001), respectively] and HFH [HR, 1.52, 2.21, and 1.70 (P = 0.049, P = 0.002, and P = 0.031), respectively]. CONCLUSIONS: Plasma volume status is useful for predicting all‐cause mortality and HFH after TAVR. |
format | Online Article Text |
id | pubmed-8120354 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81203542021-05-21 Calculated plasma volume status and outcomes in patients undergoing transcatheter aortic valve replacement Shimura, Tetsuro Yamamoto, Masanori Yamaguchi, Ryo Adachi, Yuya Sago, Mitsuru Tsunaki, Tatsuya Kagase, Ai Koyama, Yutaka Otsuka, Toshiaki Yashima, Fumiaki Tada, Norio Naganuma, Toru Yamawaki, Masahiro Yamanaka, Futoshi Shirai, Shinichi Mizutani, Kazuki Tabata, Minoru Ueno, Hiroshi Takagi, Kensuke Watanabe, Yusuke Hayashida, Kentaro ESC Heart Fail Original Research Articles AIMS: This study investigated the prognostic value of plasma volume status (PVS) in patients who underwent transcatheter aortic valve replacement (TAVR). METHODS AND RESULTS: Plasma volume status was calculated in 2588 patients who underwent TAVR using data from the Japanese multicentre registry. All‐cause mortality and heart failure hospitalization (HFH) within 2 years of TAVR were compared among the PVS quartiles (Q1, PVS < 5.5%; Q2, PVS 5.5–13.5%; Q3, PVS 13.5–21.0%; and Q4, PVS ≥ 21.0%). Subgroups were stratified by the PVS cut‐off value combined with the New York Heart Association (NYHA) class as follows: low PVS with NYHA I/II (n = 959), low PVS with NYHA III/IV (n = 845), high PVS with NYHA I/II (n = 308), and high PVS with NYHA III/IV (n = 476). The cumulative all‐cause mortality and HFH within 2 years of TAVR significantly increased with increasing PVS quartiles [8.5%, 16.8%, 19.2%, and 27.0% (P < 0.001) and 5.8%, 8.7%, 10.3%, and 12.9% (P < 0.001), respectively]. The high‐PVS group regardless of the NYHA class had a higher all‐cause mortality and HFH [9.6%, 18.2%, 24.5%, and 30.4% (P < 0.001) and 6.1%, 10.4%, 14.1%, and 11.3% (P < 0.001)]. In a Cox regression multivariate analysis, the PVS values of Q3 and Q4 had independently increased all‐cause mortality [hazard ratio (HR), 1.50 and 1.64 (P = 0.017 and P = 0.008), respectively], and Q4 had independently increased HFH (HR, 1.98, P = 0.005). The low PVS with NYHA III/IV, high PVS with NYHA I/II, and high PVS with NYHA III/IV also had significantly increased all‐cause mortality [HR, 1.45, 1.73, and 1.86 (P = 0.006, P = 0.002, and P < 0.001), respectively] and HFH [HR, 1.52, 2.21, and 1.70 (P = 0.049, P = 0.002, and P = 0.031), respectively]. CONCLUSIONS: Plasma volume status is useful for predicting all‐cause mortality and HFH after TAVR. John Wiley and Sons Inc. 2021-03-05 /pmc/articles/PMC8120354/ /pubmed/33666353 http://dx.doi.org/10.1002/ehf2.13270 Text en © 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Articles Shimura, Tetsuro Yamamoto, Masanori Yamaguchi, Ryo Adachi, Yuya Sago, Mitsuru Tsunaki, Tatsuya Kagase, Ai Koyama, Yutaka Otsuka, Toshiaki Yashima, Fumiaki Tada, Norio Naganuma, Toru Yamawaki, Masahiro Yamanaka, Futoshi Shirai, Shinichi Mizutani, Kazuki Tabata, Minoru Ueno, Hiroshi Takagi, Kensuke Watanabe, Yusuke Hayashida, Kentaro Calculated plasma volume status and outcomes in patients undergoing transcatheter aortic valve replacement |
title | Calculated plasma volume status and outcomes in patients undergoing transcatheter aortic valve replacement |
title_full | Calculated plasma volume status and outcomes in patients undergoing transcatheter aortic valve replacement |
title_fullStr | Calculated plasma volume status and outcomes in patients undergoing transcatheter aortic valve replacement |
title_full_unstemmed | Calculated plasma volume status and outcomes in patients undergoing transcatheter aortic valve replacement |
title_short | Calculated plasma volume status and outcomes in patients undergoing transcatheter aortic valve replacement |
title_sort | calculated plasma volume status and outcomes in patients undergoing transcatheter aortic valve replacement |
topic | Original Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120354/ https://www.ncbi.nlm.nih.gov/pubmed/33666353 http://dx.doi.org/10.1002/ehf2.13270 |
work_keys_str_mv | AT shimuratetsuro calculatedplasmavolumestatusandoutcomesinpatientsundergoingtranscatheteraorticvalvereplacement AT yamamotomasanori calculatedplasmavolumestatusandoutcomesinpatientsundergoingtranscatheteraorticvalvereplacement AT yamaguchiryo calculatedplasmavolumestatusandoutcomesinpatientsundergoingtranscatheteraorticvalvereplacement AT adachiyuya calculatedplasmavolumestatusandoutcomesinpatientsundergoingtranscatheteraorticvalvereplacement AT sagomitsuru calculatedplasmavolumestatusandoutcomesinpatientsundergoingtranscatheteraorticvalvereplacement AT tsunakitatsuya calculatedplasmavolumestatusandoutcomesinpatientsundergoingtranscatheteraorticvalvereplacement AT kagaseai calculatedplasmavolumestatusandoutcomesinpatientsundergoingtranscatheteraorticvalvereplacement AT koyamayutaka calculatedplasmavolumestatusandoutcomesinpatientsundergoingtranscatheteraorticvalvereplacement AT otsukatoshiaki calculatedplasmavolumestatusandoutcomesinpatientsundergoingtranscatheteraorticvalvereplacement AT yashimafumiaki calculatedplasmavolumestatusandoutcomesinpatientsundergoingtranscatheteraorticvalvereplacement AT tadanorio calculatedplasmavolumestatusandoutcomesinpatientsundergoingtranscatheteraorticvalvereplacement AT naganumatoru calculatedplasmavolumestatusandoutcomesinpatientsundergoingtranscatheteraorticvalvereplacement AT yamawakimasahiro calculatedplasmavolumestatusandoutcomesinpatientsundergoingtranscatheteraorticvalvereplacement AT yamanakafutoshi calculatedplasmavolumestatusandoutcomesinpatientsundergoingtranscatheteraorticvalvereplacement AT shiraishinichi calculatedplasmavolumestatusandoutcomesinpatientsundergoingtranscatheteraorticvalvereplacement AT mizutanikazuki calculatedplasmavolumestatusandoutcomesinpatientsundergoingtranscatheteraorticvalvereplacement AT tabataminoru calculatedplasmavolumestatusandoutcomesinpatientsundergoingtranscatheteraorticvalvereplacement AT uenohiroshi calculatedplasmavolumestatusandoutcomesinpatientsundergoingtranscatheteraorticvalvereplacement AT takagikensuke calculatedplasmavolumestatusandoutcomesinpatientsundergoingtranscatheteraorticvalvereplacement AT watanabeyusuke calculatedplasmavolumestatusandoutcomesinpatientsundergoingtranscatheteraorticvalvereplacement AT hayashidakentaro calculatedplasmavolumestatusandoutcomesinpatientsundergoingtranscatheteraorticvalvereplacement AT calculatedplasmavolumestatusandoutcomesinpatientsundergoingtranscatheteraorticvalvereplacement |